UConn Health
UConn Health Leads International Center to Develop Syphilis Vaccine
“An effective syphilis vaccine would represent a triumph for biomedical research over an ailment that has defied conventional public health strategies for prevention and control,” says Dr. Justin Radolf of UConn School of Medicine.
A New Culprit for Multiple Sclerosis Relapses
A molecule that helps blood clot may also play a role in multiple sclerosis relapses, according to a new study by a team that included researchers from UConn Health
The Hazards of Living on the Right Side of a Time Zone Border
The more we learn about circadian disruption, the better we can blunt its impact, writes Richard G. Stevens, UConn Health professor.
Missing Molecule Hobbles Cell Movement
A new UConn study finds that cells missing a certain protein on their surface can’t move normally, with implications for wound repair as well as the spread of cancer.
Dental Researchers Get at Root Causes of Cancer Patients’ Mouth Sores
Oral mucositis, a common side effect of chemotherapy, is associated with detrimental changes in the oral microbiome, says new School of Dental Medicine research.
New Dental Dean Forming Alliances to Build a Better Health Care Model
As medicine moves toward an integrated approach to care, UConn’s new dental dean sees a greater role for dental medicine in the delivery of that care.
Setting Limits to Stop the Gambling Epidemic
The balance of money collected from gambling is a transfer from the poor to the rich, says Thomas Babor, addiction researcher at UConn Health.
UConn Professors Elected to American Academy of Arts and Sciences
Dr. Cato Laurencin and physics professor Nora Berrah are among the academy's 239th class, along with former First Lady Michelle Obama, and other leaders.
New Technology Designed to Reduce Mortality Rates in Cancer Patients
A pair of Ph.D. students developed a technology that takes a patient’s tumor cells and grows them outside of the body to test different cancer treatments.
Drug Discovery Partnership with AI Biotech Company Reaps Promising Early Results
At UConn Health, the technology is being used to pursue therapeutic treatments for strokes, for which there is “an urgent need for novel therapies that can move rapidly into clinical trials,” says Rajkumar Verma.